Weekly pill could tame painful birthmarks with fewer side effects
NCT ID NCT04861064
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether taking the drug sirolimus just once a week can safely treat venous and lymphatic malformations—abnormal clusters of blood vessels or lymph vessels that can cause pain and swelling. Current daily dosing works but often causes side effects like low white blood cell counts and mouth sores. The trial will enroll 24 people aged 2 and older, who will take sirolimus weekly for 6 months, with the option to continue longer. Researchers will measure changes in lesion size and track side effects to see if weekly dosing is a good alternative.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Sirolimus (a drug that slows abnormal cell growth)
- What this could lead to
- If it works, this could offer a safer, more convenient treatment option for people with venous and lymphatic malformations, with fewer side effects than daily dosing.
- What could go wrong
- This is a small, early-phase trial with only 24 participants. The weekly dosing may not be as effective as daily dosing, and side effects like infections or mouth sores are still possible.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LYMPHATIC MALFORMATION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Medical University of South Carolina
RECRUITINGCharleston, South Carolina, 29403, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a cancer drug shrink birthmarks? bleomycin injections put to the test
- Small study examines risks of injection treatment for Children's facial vein blemishes
- New hope for rare blood vessel disorder: targeted drug shows promise
- Scientists launch global effort to unravel mysteries of rare lymphatic diseases
- New hope for rare blood vessel disorders: everolimus trial launches
- Glow-in-the-Dark dye could make Children's tumor surgery safer and more effective